SAN CARLOS, Calif.-- October 14, 2026 -- Altay Therapeutics, Inc., a biotechnology company developing novel small molecule inhibitors of transcription factors, today announced the completion of a $37 million Series...
Barry Myers will be speaking on a panel discussing financing mechanisms for emerging companies at the Life Sciences Summit 2011 in New York on November 16.
News | 11. 11. 2011
